Ooma Inc: Form 10-Q for the period ended Oct 31, 2019
Filed with the SEC on Dec 6, 2019 and accepted by EDGAR at Dec 6, 2019, 16:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-08-01 to 2019-10-31 | $39.6m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2019-02-01 to 2019-10-31 | $110.9m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2019-08-01 to 2019-10-31 | $17.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-02-01 to 2019-10-31 | $46.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-08-01 to 2019-10-31 | $22.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-02-01 to 2019-10-31 | $64.8m | us-gaap:GrossProfit |
| Research and development | 3 months2019-08-01 to 2019-10-31 | $10.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-02-01 to 2019-10-31 | $29.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2019-08-01 to 2019-10-31 | −$6.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-02-01 to 2019-10-31 | −$17.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-08-01 to 2019-10-31 | −$28.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-02-01 to 2019-10-31 | −$66.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-08-01 to 2019-10-31 | −$6.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-02-01 to 2019-10-31 | −$16.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-08-01 to 2019-10-31 | −$0.32 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2019-02-01 to 2019-10-31 | −$0.79 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2019-02-01 to 2019-10-31 | −$6.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2019-10-31 | $11.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-10-31 | $50.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-10-31 | $78.7m | us-gaap:Assets |
| Current liabilities | At period end2019-10-31 | $48.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-10-31 | $51.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-10-31 | $27.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-19-045480. Last ingested by Listed: Oct 27, 2026, 16:11 ET. Listed shows no prices and gives no investment advice.